Fw: repost - SILICONE GEL CAUSES RARE FORM OF CANCER

[Guest guest]

----- Original Message -----

From: " Kathi " <pureheart@...>

Sent: Sunday, October 06, 2002 12:22 PM

Subject: repost - SILICONE GEL CAUSES RARE FORM OF CANCER

> Could you please post this again.

>

> Thank you...love....Lea

>

> Many questions regarding this article???????

>

> ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

> ----- Original Message -----

> From: " Kathi " <pureheart@...>

> <undisclosed-recipients:>

> Sent: Sunday, August 11, 2002 8:54 AM

> Subject: SILICONE GEL CAUSES RARE FORM OF CANCER

>

>

> > Title: SILICONE GEL CAUSES RARE FORM OF CANCER , By: Key, K.,

> > DeNoon, J., Cancer Researcher Weekly, 10717226,

> 07/25/94-08/01/94

> >

> > Database: Academic Search Elite

> > Section: News Report; Informative Briefs from Worldwide Sources Study

> >

> > SILICONE GEL CAUSES RARE FORM OF CANCER

> >

> > A study conducted by researchers at the U.S. National Cancer Institute

>

> > (NCI) has found silicone gel from breast implants injected into mice

> > causes cancer, known as plasmacytomas

> > (PCTs). PCT's human equivalent is a rare form of cancer in the

> > respiratory tract and nasopharynx, according to an article in the July

>

> > 12, 1994, issue of Mealey's Litigation Report:

> > Breast Implants.

> > A copy of the study, published in the July 20, 1994, edition of the

> > Journal of the National Cancer Institute, was obtained by Mealey

> > Publications, Wayne, Pennsylvania.

> > The study's release follows the release of a Mayo Clinic study which

> > found no autoimmune disease link to silicone breast implants, a study

> > disputed by some doctors.

> > PCT in mice is the equivalent of extramedullary plasmacytomas (EMP) in

>

> > humans, a rare human cancer which attacks the upper respiratory tract,

>

> > nasopharynx and, sometimes, the

> > gastrointestinal tract.

> > The researchers suggest, given their findings and reports of immune

> > stimulating effects of silicone gel, further research should be

> > conducted of the development of monoclonal

> > gammopathies of undetermined significance and myeloma.

> > The researchers in the cancer study used silicone gel from breast

> > implants, injecting the gel intraperitoneally over a period of time

> into

> > genetically susceptible mice. The animals were

> > observed for signs of PCT and were autopsied 125 to 400 days after

> > injection. The silicone gel involved in the study was taken from Dow

> > Corning implants (Silastic II Mammary Implant

> > H.P., Lots No. HH046154P and No. HH058733).

> > A control group of mice was injected with corn oil over the same

> period

> > of time; no PCT was found in the control group.

> > Reporting the results of preliminary experiments, the doctors said in

> a

> > single intraperitoneal injection of 0.2 to 0.4 ml of the gel, the mice

>

> > had a 20 to 55 percent incidence of PCTs,

> > while three injections over a 20-day period of a 0.1 to 0.2 ml had an

> > incidence rate of 80 percent.

> > " This study is the first to link silicone gel to cancer, " said

> > Storey, editor of Mealey's Litigation Report: Breast Implants. " It

> > follows the release of the Mayo Clinic study which

> > favored defendants showing no autoimmune disease link to implants.

> > Similarly, the cancer study will add fuel to the debate over the

> safety

> > of silicone gel breast implants. "

> > ~~~~~~~~

> > K. Key, News Editor, with J. DeNoon

> >

> > Copyright of Cancer Researcher Weekly is the property of CW

> > and its content may not be copied or emailed to multiple sites or

> posted

> > to a listserv without the copyright

> > holder's express written permission. However, users may print,

> download,

> > or email articles for individual use.

> > Source: Cancer Researcher Weekly, 07/25/94-08/01/94, p3, 1p

> > Item: 9409222597

> >

>

>

>

>